Chengdu Kanghua (China) Performance
| 300841 Stock | 58.10 0.10 0.17% |
On a scale of 0 to 100, Chengdu Kanghua holds a performance score of 8. The firm shows a Beta (market volatility) of 0.0581, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Chengdu Kanghua's returns are expected to increase less than the market. However, during the bear market, the loss of holding Chengdu Kanghua is expected to be smaller as well. Please check Chengdu Kanghua's market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to make a quick decision on whether Chengdu Kanghua's price patterns will revert.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Chengdu Kanghua Biological are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Chengdu Kanghua sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0344 | Payout Ratio 0.4886 | Last Split Factor 1.5:1 | Forward Dividend Rate 2 | Ex Dividend Date 2024-05-08 |
1 | Baoxiniao Holding Leads Our Top 3 Dividend Stocks - Yahoo Finance | 11/08/2024 |
| Begin Period Cash Flow | 636 M |
Chengdu |
Chengdu Kanghua Relative Risk vs. Return Landscape
If you would invest 4,632 in Chengdu Kanghua Biological on September 12, 2024 and sell it today you would earn a total of 1,178 from holding Chengdu Kanghua Biological or generate 25.43% return on investment over 90 days. Chengdu Kanghua Biological is generating 0.5103% of daily returns and assumes 4.8781% volatility on return distribution over the 90 days horizon. Simply put, 43% of stocks are less volatile than Chengdu, and 90% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Chengdu Kanghua Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chengdu Kanghua's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chengdu Kanghua Biological, and traders can use it to determine the average amount a Chengdu Kanghua's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1046
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 300841 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.88 actual daily | 43 57% of assets are more volatile |
Expected Return
| 0.51 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 8 92% of assets perform better |
Based on monthly moving average Chengdu Kanghua is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chengdu Kanghua by adding it to a well-diversified portfolio.
Chengdu Kanghua Fundamentals Growth
Chengdu Stock prices reflect investors' perceptions of the future prospects and financial health of Chengdu Kanghua, and Chengdu Kanghua fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chengdu Stock performance.
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.33 % | ||||
| Operating Margin | 0.36 % | ||||
| Current Valuation | 7.26 B | ||||
| Shares Outstanding | 134.65 M | ||||
| Price To Book | 2.26 X | ||||
| Price To Sales | 4.71 X | ||||
| Revenue | 1.58 B | ||||
| Gross Profit | 1.34 B | ||||
| EBITDA | 735.65 M | ||||
| Net Income | 509.22 M | ||||
| Total Debt | 190.91 M | ||||
| Book Value Per Share | 26.59 X | ||||
| Cash Flow From Operations | 573.98 M | ||||
| Earnings Per Share | 4.12 X | ||||
| Total Asset | 4.21 B | ||||
| Retained Earnings | 2.26 B | ||||
About Chengdu Kanghua Performance
By analyzing Chengdu Kanghua's fundamental ratios, stakeholders can gain valuable insights into Chengdu Kanghua's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Chengdu Kanghua has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Chengdu Kanghua has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Chengdu Kanghua is entity of China. It is traded as Stock on SHE exchange.Things to note about Chengdu Kanghua Biol performance evaluation
Checking the ongoing alerts about Chengdu Kanghua for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Chengdu Kanghua Biol help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Chengdu Kanghua Biol appears to be risky and price may revert if volatility continues | |
| About 35.0% of the company shares are owned by insiders or employees |
- Analyzing Chengdu Kanghua's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chengdu Kanghua's stock is overvalued or undervalued compared to its peers.
- Examining Chengdu Kanghua's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chengdu Kanghua's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chengdu Kanghua's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chengdu Kanghua's stock. These opinions can provide insight into Chengdu Kanghua's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Chengdu Stock analysis
When running Chengdu Kanghua's price analysis, check to measure Chengdu Kanghua's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chengdu Kanghua is operating at the current time. Most of Chengdu Kanghua's value examination focuses on studying past and present price action to predict the probability of Chengdu Kanghua's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chengdu Kanghua's price. Additionally, you may evaluate how the addition of Chengdu Kanghua to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |